Novel hemostatic alternatives in reconstructive surgery.
D001165:Arteriovenous Malformations / Q000601:surgery; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D005167:Factor VII / Q000627:therapeutic use*; D015942:Factor VIIa; D006258:Head and Neck Neoplasms / Q000601:surgery*; D006391:Hemangioma / Q000601:surgery*; D006488:Hemostasis, Surgical / Q000379:methods*; D006801:Humans; D007223:Infant; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use*; D019651:Plastic Surgery Procedures / Q000379:methods*; D014060:Tongue Diseases / Q000601:surgery
D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa